Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
(Approval lapsed) Cisatracurium - hameln 2mg/mL solution for injection/infusion 10mg/5mL ampoules (Germany)
Section 19A approved medicine
(Approval lapsed) Cisatracurium - hameln 2mg/mL solution for injection/infusion 10mg/5mL ampoules (Germany)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 517
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
CISATRACURIUM JUNO Cisatracurium besilate 5mg/2.5mL Solution for Injection ampoule - AUSTR 226854
CISATRACURIUM JUNO cisatracurium (as besilate) 10mg/5mL Solution for Injection ampoule - AUSTR 226857
CISATRACURIUM JUNO cisatracurium (as besilate) 10mg/5mL Solution for Injection ampoule - AUSTR 226857
Indication(s)
Cisatracurium is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation.It is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.